BNP Paribas Financial Markets’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $387K | Sell |
4,028
-24,807
| -86% | -$2.54M | ﹤0.01% | 3894 |
|
|
2026
Q1 | $3.15M | Buy |
28,835
+20,342
| +240% | +$1.94M | ﹤0.01% | 2365 |
|
|
2025
Q4 | $689K | Buy |
8,493
+345
| +4% | +$29.7K | ﹤0.01% | 3380 |
|
|
2025
Q3 | $713K | Sell |
8,148
-467
| -5% | -$41.7K | ﹤0.01% | 3368 |
|
|
2025
Q2 | $715K | Sell |
8,615
-10,910
| -56% | -$912K | ﹤0.01% | 3103 |
|
|
2025
Q1 | $1.64M | Sell |
19,525
-9,178
| -32% | -$854K | ﹤0.01% | 2479 |
|
|
2024
Q4 | $2.64M | Buy |
28,703
+874
| +3% | +$84K | ﹤0.01% | 2206 |
|
|
2024
Q3 | $2.59M | Buy |
27,829
+12,432
| +81% | +$1.08M | ﹤0.01% | 1909 |
|
|
2024
Q2 | $1.27M | Sell |
15,397
-7,520
| -33% | -$552K | ﹤0.01% | 2156 |
|
|
2024
Q1 | $1.52M | Buy |
22,917
+13,189
| +136% | +$814K | ﹤0.01% | 2227 |
|
|
2023
Q4 | $552K | Sell |
9,728
-6,567
| -40% | -$344K | ﹤0.01% | 2738 |
|
|
2023
Q3 | $888K | Buy |
16,295
+7,260
| +80% | +$430K | ﹤0.01% | 2398 |
|
|
2023
Q2 | $608K | Sell |
9,035
-2,481
| -22% | -$151K | ﹤0.01% | 2490 |
|
|
2023
Q1 | $593K | Buy |
11,516
+8,252
| +253% | +$401K | ﹤0.01% | 2633 |
|
|
2022
Q4 | $150K | Sell |
3,264
-5,572
| -63% | -$261K | ﹤0.01% | 3105 |
|
|
2022
Q3 | $448K | Buy |
8,836
+3,475
| +65% | +$174K | ﹤0.01% | 3048 |
|
|
2022
Q2 | $244K | Sell |
5,361
-3,721
| -41% | -$166K | ﹤0.01% | 2998 |
|
|
2022
Q1 | $422K | Sell |
9,082
-3,814
| -30% | -$171K | ﹤0.01% | 2835 |
|
|
2021
Q4 | $648K | Sell |
12,896
-5,525
| -30% | -$286K | ﹤0.01% | 2873 |
|
|
2021
Q3 | $978K | Buy |
18,421
+12,355
| +204% | +$696K | ﹤0.01% | 2386 |
|
|
2021
Q2 | $370K | Buy |
6,066
+1,997
| +49% | +$106K | ﹤0.01% | 2670 |
|
|
2021
Q1 | $198K | Buy |
4,069
+548
| +16% | +$25.7K | ﹤0.01% | 3054 |
|
|
2020
Q4 | $143K | Sell |
3,521
-698
| -17% | -$24.9K | ﹤0.01% | 3045 |
|
|
2020
Q3 | $137K | Buy |
4,219
+3,233
| +328% | +$97.1K | ﹤0.01% | 2945 |
|
|
2020
Q2 | $26K | Sell |
986
-5,552
| -85% | -$145K | ﹤0.01% | 3277 |
|
|
2020
Q1 | $163K | Buy |
6,538
+2,872
| +78% | +$88.7K | ﹤0.01% | 2965 |
|
|
2019
Q4 | $132K | Buy |
3,666
+1,116
| +44% | +$38.5K | ﹤0.01% | 3158 |
|
|
2019
Q3 | $87.2K | Buy |
2,550
+533
| +26% | +$17K | ﹤0.01% | 3198 |
|
|
2019
Q2 | $56.4K | Sell |
2,017
-1,320
| -40% | -$36.7K | ﹤0.01% | 3346 |
|
|
2019
Q1 | $103K | Buy |
3,337
+3,332
| +66,640% | +$88.9K | ﹤0.01% | 3102 |
|
|
2018
Q4 | $118 | Sell |
5
-494
| -99% | -$13.5K | ﹤0.01% | 4164 |
|
|
2018
Q3 | $19.3K | Sell |
499
-1,264
| -72% | -$45.5K | ﹤0.01% | 3428 |
|
|
2018
Q2 | $59K | Sell |
1,763
-3,223
| -65% | -$115K | ﹤0.01% | 3047 |
|
|
2018
Q1 | $181K | Sell |
4,986
-1,211
| -20% | -$41.9K | ﹤0.01% | 2849 |
|
|
2017
Q4 | $197K | Sell |
6,197
-1,208
| -16% | -$41.4K | ﹤0.01% | 2972 |
|
|
2017
Q3 | $277K | Buy |
7,405
+3,657
| +98% | +$124K | ﹤0.01% | 2297 |
|
|
2017
Q2 | $117K | Buy |
3,748
+3,716
| +11,613% | +$107K | ﹤0.01% | 2744 |
|
|
2017
Q1 | $788 | Sell |
32
-658
| -95% | -$15.4K | ﹤0.01% | 3748 |
|
|
2016
Q4 | $17.5K | Sell |
690
-334
| -33% | -$7.41K | ﹤0.01% | 3242 |
|
|
2016
Q3 | $20.3K | Buy |
1,024
+538
| +111% | +$9.4K | ﹤0.01% | 2885 |
|
|
2016
Q2 | $6.93K | Buy |
+486
| New | +$7.43K | ﹤0.01% | 3103 |
|
|
2016
Q1 | – | Sell |
-1,167
| Closed | -$20.1K | – | 2894 |
|
|
2015
Q4 | $20.1K | Sell |
1,167
-1,196
| -51% | -$17.3K | ﹤0.01% | 2907 |
|
|
2015
Q3 | $28.8K | Buy |
2,363
+1,375
| +139% | +$17.6K | ﹤0.01% | 3182 |
|
|
2015
Q2 | $11.9K | Buy |
+988
| New | +$9.73K | ﹤0.01% | 3290 |
|
Other funds holding LMAT
CCA
CAM
CCM
BNP Paribas Financial Markets's LMAT Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its LeMaitre Vascular (LMAT) stake by 86% in Q2 2026, selling an estimated $2.54M and leaving 4,028 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #3894.
BNP Paribas Financial Markets first reported a position in LMAT in Q2 2015 and has held it in 44 quarters since. The position peaked at $3.15M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- BNP Paribas Financial Markets held 4,028 shares of LeMaitre Vascular worth $387K as of Q2 2026.
- BNP Paribas Financial Markets sold 24,807 LeMaitre Vascular shares in Q2 2026, an estimated $2.54M.
- LeMaitre Vascular made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3894 holding.
- BNP Paribas Financial Markets first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 44 quarters since.
- BNP Paribas Financial Markets's LeMaitre Vascular position peaked at $3.15M in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.